What does DOKTER J.W. VERSTRATEN do?

DOKTER J.W. VERSTRATEN is a specialist medical practice in Mol. Private Limited, started on 21 November 2001, 1 establishment.

What is the address of DOKTER J.W. VERSTRATEN?

The registered office of DOKTER J.W. VERSTRATEN is located at De Rooy 17, 2400 Mol.

Is DOKTER J.W. VERSTRATEN still active?

Yes. According to the CBE (31 October 2026) DOKTER J.W. VERSTRATEN is active, legal situation “Normale toestand”, started on 21 November 2001.

Is DOKTER J.W. VERSTRATEN registered on Peppol?

Yes, DOKTER J.W. VERSTRATEN is registered on the Peppol network with ID 0208:0476124795.

What is the enterprise number of DOKTER J.W. VERSTRATEN?

The enterprise number of DOKTER J.W. VERSTRATEN is BE0476124795.

When was DOKTER J.W. VERSTRATEN founded?

DOKTER J.W. VERSTRATEN was founded on 21 November 2001.

Who are the directors of DOKTER J.W. VERSTRATEN?

According to the 2026 annual accounts, the directors of DOKTER J.W. VERSTRATEN are: JAN WILLEM VERSTRATEN.

Is DOKTER J.W. VERSTRATEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 November 2001; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account.

How much profit did DOKTER J.W. VERSTRATEN make in 2026?

DOKTER J.W. VERSTRATEN posted a profit after taxes of € 133,512 in financial year 2026.

What is the revenue of DOKTER J.W. VERSTRATEN?

As a small company, DOKTER J.W. VERSTRATEN is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 225,685.

DOKTER J.W. VERSTRATEN (Private Limited) - Mol

Dossier DOKTER J.W. VERSTRATEN, printed on 1 November 2026 from databakkes.be/en/0476124795/dokter-j-w-verstraten. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

DOKTER J.W. VERSTRATEN from Mol, company number BE0476124795, closed financial year 2026 with a result of € 133,512 after tax. For that financial year DOKTER J.W. VERSTRATEN recorded a gross margin of € 225,685 and equity of € 711,261. Compared with financial year 2025, the result moved from € 198,190 to € 133,512. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 14, 2026.

What it is worth Growing

€ 711,261

▲ 23% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 133,512

▼ 33% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 377,816

▲ 56% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 692,661.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 8,011

▲ € 7,104 vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 5,786

▼ 80% vs 2025

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 101,050 Gross margin 2023: € 101,050 First fiscal year in the series	€ 231,830 Gross margin 2024: € 231,830 ▲ 129% vs 2023 (€ 101,050) Favourable step	€ 316,489 Gross margin 2025: € 316,489 ▲ 37% vs 2024 (€ 231,830) Favourable step	€ 225,685 Gross margin 2026: € 225,685 ▼ 29% vs 2025 (€ 316,489) Unfavourable step	▼ 29%
Profit after taxes	€ 60,147 Profit after taxes 2023: € 60,147 First fiscal year in the series	€ 140,460 Profit after taxes 2024: € 140,460 ▲ 134% vs 2023 (€ 60,147) Favourable step	€ 198,190 Profit after taxes 2025: € 198,190 ▲ 41% vs 2024 (€ 140,460) Favourable step	€ 133,512 Profit after taxes 2026: € 133,512 ▼ 33% vs 2025 (€ 198,190) Unfavourable step	▼ 33%
Equity	€ 371,603 Equity 2023: € 371,603 First fiscal year in the series	€ 379,559 Equity 2024: € 379,559 ▲ 2% vs 2023 (€ 371,603) Favourable step	€ 577,749 Equity 2025: € 577,749 ▲ 52% vs 2024 (€ 379,559) Favourable step	€ 711,261 Equity 2026: € 711,261 ▲ 23% vs 2025 (€ 577,749) Favourable step	▲ 23%
Total debts	€ 178,587 Total debts 2023: € 178,587 First fiscal year in the series	€ 344,807 Total debts 2024: € 344,807 ▲ 93% vs 2023 (€ 178,587) Unfavourable step	€ 348,857 Total debts 2025: € 348,857 ▲ 1% vs 2024 (€ 344,807) Unfavourable step	€ 215,139 Total debts 2026: € 215,139 ▼ 38% vs 2025 (€ 348,857) Favourable step	▼ 38%
Cash	€ 110,268 Cash 2023: € 110,268 First fiscal year in the series	€ 132,690 Cash 2024: € 132,690 ▲ 20% vs 2023 (€ 110,268) Favourable step	€ 242,544 Cash 2025: € 242,544 ▲ 83% vs 2024 (€ 132,690) Favourable step	€ 377,816 Cash 2026: € 377,816 ▲ 56% vs 2025 (€ 242,544) Favourable step	▲ 56%
Retained profit	€ 353,003 Retained profit 2023: € 353,003 First fiscal year in the series	€ 360,959 Retained profit 2024: € 360,959 ▲ 2% vs 2023 (€ 353,003) Favourable step	€ 559,149 Retained profit 2025: € 559,149 ▲ 55% vs 2024 (€ 360,959) Favourable step	€ 692,661 Retained profit 2026: € 692,661 ▲ 24% vs 2025 (€ 559,149) Favourable step	▲ 24%
Dividend	€ 69,591 Dividend 2023: € 69,591 First fiscal year in the series	€ 132,504 Dividend 2024: € 132,504 ▲ 90% vs 2023 (€ 69,591) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 132,504) Unchanged	€ 0 Dividend 2026: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 550,190 Balance sheet total 2023: € 550,190 First fiscal year in the series	€ 724,366 Balance sheet total 2024: € 724,366 ▲ 32% vs 2023 (€ 550,190) Unchanged	€ 926,606 Balance sheet total 2025: € 926,606 ▲ 28% vs 2024 (€ 724,366) Unchanged	€ 926,401 Balance sheet total 2026: € 926,401 Unchanged (€ 926,606) Unchanged

Key figures of DOKTER J.W. VERSTRATEN, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to DOKTER J.W. VERSTRATEN?

What happened at DOKTER J.W. VERSTRATEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 14, 2026 New annual accounts for financial year 2026: profit of € 133,512 (▼ 33% vs 2025). Source: NBB ↗
2011 JAN WILLEM VERSTRATEN became a director. NBB
Nov 21, 2001 Start of the company according to the CBE. KBO
Oct 30, 2001 New establishment in Mol. KBO

In short

From € 60,147 profit in 2023 to € 133,512 profit in 2026.

Paid € 238,338 in corporate taxes since 2023.

Best year ever: 2025, with € 198,190 profit.

Paid out € 202,095 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

JAN WILLEM VERSTRATEN

DOKTER J.W. VERSTRATEN

Behind DOKTER J.W. VERSTRATEN is JAN WILLEM VERSTRATEN.

Directors

According to the 2026 annual accounts

JAN WILLEM VERSTRATEN

Director

since 2011

Establishments

Establishment units

Physical locations of this company

Registered office

De Rooy 17

2400 Mol

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0476.124.795
VAT number: BE 0476.124.795
Registered office: De Rooy 17, 2400 Mol
Names & denominations: DOKTER J.W. VERSTRATEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 November 2001
Peppol: Active · Active since 5 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗